AzTrials
AzTrials

Inguinal HerniaWire vs ProlenNCT05879770

Is the Use of Prolene as Sufficient as the Use of Wire in Shouldice Surgery to Keep the Recurrence Rate Low After One Year?

An observational study of Inguinal Hernia, run by Shouldice Hospital at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

When conducting the Shouldice procedure the 4-layer suture of the transversalis fascia is usually done with Prolene worldwide. At the Shouldice hospital the wire has originally been used for these augmentation. Read more about this study

Who is it for?
Ages 16 years and olderHealthy volunteers can take part
Conditions the study is for
Inguinal Hernia
What is being tested?
suture material
How many people
1,400 participants
Where
1 siteCanada
Study dates
1 Sep 2023to 1 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Adult patients of all sexes who have undergone inguinal hernia surgery in Shouldice technique.

Who may be able to join

  • Adult patients of all sexes who have undergone inguinal hernia surgery in Shouldice technique.

Who cannot join

  • Hernia repair using a mesh

Trial locations and contacts

1 site in 1 country.

Canada1 site, 1 recruiting
  • Shouldice Hospital

    Thornhill, Ontario, L3T 4A3,

    Marguerite Mainprize, MSc, 905-889-1125 ext. 1297, mmainprize@shouldice.com

    Fernando Netto Spencer, PhD, 905-889-1125 ext. 1297, fspencernetto@shouldice.com

    Recruiting

Other trials in Canada

About this study

When conducting the Shouldice procedure the 4-layer suture of the transversalis fascia is usually done with Prolene worldwide. At the Shouldice hospital the wire has originally been used for these augmentation. During the last decade several Shouldice Surgeons started to use the Prolene due to occasional delivery problems of the wire from Germany.

The 1-year- recurrence rate at the Shouldice hospital is 1,15% (mainly wire-use). The published 1-year recurrence rate in Europe is 2%.

As quality assessment, this project intends to evaluate these two options for suturing (wire vs Prolene) in the elective inguinal hernia patient in terms of 1-year recurrence rate. The population of focus will be those who had a primary or secondary inguinal hernia operation at Shouldice Hospital and the project is estimated to take 3 months.

Read the detailed description
  1. Study design A total of 1400 patients (n=700 with wire; n=700 with Prolene) who underwent Shouldice surgery at Shouldice Hospital will be contacted by telephone. They will be asked whether a relapse occurred after their surgery.

Sample size calculation:

The 1-year recurrence rate at Shouldice Hospital is 1.15% (mainly wire use). The published 1-year recurrence rate in Europe is 2% [1-3]. Statistics: non-inferiority: delta for non-inferiority (defined equivalence range) = 1%. Total N = 1120 (0% dropout), with 20% dropout: N = 1400.) The same number of patients will be analyzed with regard to Shouldice repair due to a first relapse (time period of data extraction 2019-2021).

Since over 6000 hernias are operated annually, a consecutive data extraction of patients operated in 2021 will be performed.

Conditions
Inguinal Hernia
Being tested
suture material
Keywords
Hernia, Shouldice Repair, groin hernia
Medical subject headings
Hernia, Inguinal, Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • suture materialOther

    Some patients have had a shouldice repair with wire in the past and others with Prolene.

Study groups in NCT05879770
Study groupRoleWhat they receive
Wire groupPatients who underwent Shouldice inguinal hernia repair using wire.
Receives: Other: suture material
prolene groupPatients who underwent Shouldice inguinal hernia repair using prolene.
Receives: Other: suture material

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recurrence rate

    One-year recurrence rate

    Measured: 1 year

Secondary outcomes (1)
  1. Reoperation rate due to a recurrence

    Reoperation rate due to a recurrence

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2023
  2. Study start1 Sep 2023 (estimated)
  3. Primary completion1 Jan 2024 (estimated)
  4. Study completion1 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05879770
Sponsor's protocol ID
#2023-02
Acronym
Wire vs Prolen
Status last verified
May 2023
First submitted
18 May 2023
Last updated
30 May 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Inguinal Hernia, run by Shouldice Hospital at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recurrence rate (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in